259 related articles for article (PubMed ID: 21563866)
1. Aripiprazole and haloperidol in the treatment of delirium.
Boettger S; Friedlander M; Breitbart W; Passik S
Aust N Z J Psychiatry; 2011 Jun; 45(6):477-82. PubMed ID: 21563866
[TBL] [Abstract][Full Text] [Related]
2. An open trial of aripiprazole for the treatment of delirium in hospitalized cancer patients.
Boettger S; Breitbart W
Palliat Support Care; 2011 Dec; 9(4):351-7. PubMed ID: 22104410
[TBL] [Abstract][Full Text] [Related]
3. Haloperidol, risperidone, olanzapine and aripiprazole in the management of delirium: A comparison of efficacy, safety, and side effects.
Boettger S; Jenewein J; Breitbart W
Palliat Support Care; 2015 Aug; 13(4):1079-85. PubMed ID: 25191793
[TBL] [Abstract][Full Text] [Related]
4. Aripiprazole in the treatment of delirium.
Straker DA; Shapiro PA; Muskin PR
Psychosomatics; 2006; 47(5):385-91. PubMed ID: 16959926
[TBL] [Abstract][Full Text] [Related]
5. Combination treatment with aripiprazole and valproic acid for acute mania: an 8-week, single-blind, randomized controlled trial.
Jeong HG; Lee MS; Ko YH; Han C; Jung IK
Clin Neuropharmacol; 2012; 35(3):97-102. PubMed ID: 22592508
[TBL] [Abstract][Full Text] [Related]
6. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial.
Barbui C; Accordini S; Nosè M; Stroup S; Purgato M; Girlanda F; Esposito E; Veronese A; Tansella M; Cipriani A;
J Clin Psychopharmacol; 2011 Jun; 31(3):266-73. PubMed ID: 21508849
[TBL] [Abstract][Full Text] [Related]
7. Aripiprazole in the treatment of delirium.
Alao AO; Soderberg M; Pohl EL; Koss M
Int J Psychiatry Med; 2005; 35(4):429-33. PubMed ID: 16673842
[TBL] [Abstract][Full Text] [Related]
8. Intramuscular aripiprazole or haloperidol and transition to oral therapy in patients with agitation associated with schizophrenia: sub-analysis of a double-blind study.
Andrezina R; Marcus RN; Oren DA; Manos G; Stock E; Carson WH; McQuade RD
Curr Med Res Opin; 2006 Nov; 22(11):2209-19. PubMed ID: 17076982
[TBL] [Abstract][Full Text] [Related]
9. The efficacy, safety, and tolerability of aripiprazole for the treatment of schizoaffective disorder: results from a pooled analysis of a sub-population of subjects from two randomized, double-blind, placebo-controlled, pivotal trials.
Glick ID; Mankoski R; Eudicone JM; Marcus RN; Tran QV; Assunção-Talbott S
J Affect Disord; 2009 May; 115(1-2):18-26. PubMed ID: 19230981
[TBL] [Abstract][Full Text] [Related]
10. Trial of aripiprazole in the treatment of first-episode schizophrenia.
Lee HY; Ham BJ; Kang RH; Paik JW; Hahn SW; Lee MS; Lee MS
Psychiatry Clin Neurosci; 2010 Feb; 64(1):38-43. PubMed ID: 20416024
[TBL] [Abstract][Full Text] [Related]
11. Phenomenology of the subtypes of delirium: phenomenological differences between hyperactive and hypoactive delirium.
Boettger S; Breitbart W
Palliat Support Care; 2011 Jun; 9(2):129-35. PubMed ID: 24468480
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations.
Daniel DG; Currier GW; Zimbroff DL; Allen MH; Oren D; Manos G; McQuade R; Pikalov AA; Crandall DT
J Psychiatr Pract; 2007 May; 13(3):170-7. PubMed ID: 17522560
[TBL] [Abstract][Full Text] [Related]
13. [Effects of mianserin hydrochloride on delirium: comparison with the effects of oxypertine and haloperidol].
Nakamura J; Uchimura N; Yamada S; Nakazawa Y
Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Aug; 14(4):269-77. PubMed ID: 7975931
[TBL] [Abstract][Full Text] [Related]
14. Aripiprazole and delirium.
Alao AO; Moskowitz L
Ann Clin Psychiatry; 2006; 18(4):267-9. PubMed ID: 17162627
[TBL] [Abstract][Full Text] [Related]
15. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients.
Breitbart W; Marotta R; Platt MM; Weisman H; Derevenco M; Grau C; Corbera K; Raymond S; Lund S; Jacobson P
Am J Psychiatry; 1996 Feb; 153(2):231-7. PubMed ID: 8561204
[TBL] [Abstract][Full Text] [Related]
16. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN
Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
[TBL] [Abstract][Full Text] [Related]
17. Aripiprazole and haloperidol: beneficial combination antipsychotic therapy for a schizophrenic patient.
Kuo J; Hwu HG
Clin Neuropharmacol; 2008; 31(3):173-5. PubMed ID: 18520984
[TBL] [Abstract][Full Text] [Related]
18. An open-label study of the efficacy and tolerability of aripiprazole for children and adolescents with tic disorders.
Yoo HK; Choi SH; Park S; Wang HR; Hong JP; Kim CY
J Clin Psychiatry; 2007 Jul; 68(7):1088-93. PubMed ID: 17685747
[TBL] [Abstract][Full Text] [Related]
19. Effect of aripiprazole on cognition in the treatment of patients with schizophrenia.
Riedel M; Spellmann I; Schennach-Wolff R; Musil R; Dehning S; Cerovecki A; Opgen-Rhein M; Matz J; Seemüller F; Obermeier M; Severus E; Engel RR; Müller N; Möller HJ
Pharmacopsychiatry; 2010 Mar; 43(2):50-7. PubMed ID: 20336597
[TBL] [Abstract][Full Text] [Related]
20. Aripiprazole for Tourette's syndrome: a systematic review and meta-analysis.
Zheng W; Li XB; Xiang YQ; Zhong BL; Chiu HF; Ungvari GS; Ng CH; Lok GK; Xiang YT
Hum Psychopharmacol; 2016 Jan; 31(1):11-8. PubMed ID: 26310194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
